Copyright
©2011 Baishideng Publishing Group Co.
World J Gastroenterol. Feb 21, 2011; 17(7): 867-897
Published online Feb 21, 2011. doi: 10.3748/wjg.v17.i7.867
Published online Feb 21, 2011. doi: 10.3748/wjg.v17.i7.867
AJCC 6th edition TNM staging system for pancreatic cancer | ||
TX | Primary tumor cannot be assessed | |
T0 | No evidence of primary tumor | |
Tis | Carcinoma in situ | |
T1 | Tumor limited to the pancreas, 2 cm or less in greatest diameter | |
T2 | Tumor limited to the pancreas, greater than 2 cm at greatest diameter | |
T3 | Tumor extends beyond pancreas but no involvement of celiac axis or superior mestenteric artery | |
T4 | Tumor involves the celiac axis or the superior mestenteric artery (unresectable) | |
NX | Regional nodes cannot be assessed | |
N0 | No regional lymph node metastasis | |
N1 | Regional lymph node metastasis | |
MX | Distant metastasis cannot be assessed | |
M0 | No distant metastasis | |
M1 | Distant metastasis | |
Stage grouping | ||
Stage 0 | Tis N0 M0 | Localized within pancreas |
Stage IA | T1 N0 M0 | Localized within pancreas |
Stage IB | T2 N0 M0 | Localized within pancreas |
Stage IIA | T3 N0 M0 | Locally invasive, resectable |
Stage IIB | T1, 2, or 3 N1 M0 | Locally invasive, resectable |
Stage III | T4 Any N M0 | Locally advanced, unresectable |
Stage IV | Any T Any N M1 | Distant metastases |
- Citation: Sharma C, Eltawil KM, Renfrew PD, Walsh MJ, Molinari M. Advances in diagnosis, treatment and palliation of pancreatic carcinoma: 1990-2010. World J Gastroenterol 2011; 17(7): 867-897
- URL: https://www.wjgnet.com/1007-9327/full/v17/i7/867.htm
- DOI: https://dx.doi.org/10.3748/wjg.v17.i7.867